Free Trial

Charles River Laboratories International (CRL) Competitors

$214.79
-6.83 (-3.08%)
(As of 06/7/2024 ET)

CRL vs. A, MTD, WAT, ILMN, TECH, BRKR, BIO, PACB, HBIO, and LIFE

Should you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bruker (BRKR), Bio-Rad Laboratories (BIO), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and aTyr Pharma (LIFE). These companies are all part of the "life sciences tools & services" industry.

Charles River Laboratories International vs.

Charles River Laboratories International (NYSE:CRL) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation, earnings and community ranking.

Charles River Laboratories International has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500.

Charles River Laboratories International currently has a consensus price target of $256.38, suggesting a potential upside of 19.37%. Agilent Technologies has a consensus price target of $136.50, suggesting a potential upside of 2.65%. Given Charles River Laboratories International's stronger consensus rating and higher possible upside, equities analysts clearly believe Charles River Laboratories International is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charles River Laboratories International
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.62
Agilent Technologies
1 Sell rating(s)
6 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.50

Agilent Technologies has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Charles River Laboratories International$4.11B2.69$474.62M$8.5025.27
Agilent Technologies$6.59B5.89$1.24B$4.2331.44

98.9% of Charles River Laboratories International shares are held by institutional investors. Comparatively, 87.4% of Agilent Technologies shares are held by institutional investors. 1.3% of Charles River Laboratories International shares are held by insiders. Comparatively, 0.3% of Agilent Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Agilent Technologies received 371 more outperform votes than Charles River Laboratories International when rated by MarketBeat users. Likewise, 71.64% of users gave Agilent Technologies an outperform vote while only 61.53% of users gave Charles River Laboratories International an outperform vote.

CompanyUnderperformOutperform
Charles River Laboratories InternationalOutperform Votes
483
61.53%
Underperform Votes
302
38.47%
Agilent TechnologiesOutperform Votes
854
71.64%
Underperform Votes
338
28.36%

In the previous week, Agilent Technologies had 4 more articles in the media than Charles River Laboratories International. MarketBeat recorded 24 mentions for Agilent Technologies and 20 mentions for Charles River Laboratories International. Charles River Laboratories International's average media sentiment score of 0.67 beat Agilent Technologies' score of 0.47 indicating that Charles River Laboratories International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Charles River Laboratories International
8 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Agilent Technologies
11 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Agilent Technologies has a net margin of 18.84% compared to Charles River Laboratories International's net margin of 10.81%. Agilent Technologies' return on equity of 26.25% beat Charles River Laboratories International's return on equity.

Company Net Margins Return on Equity Return on Assets
Charles River Laboratories International10.81% 15.16% 6.60%
Agilent Technologies 18.84%26.25%14.45%

Summary

Agilent Technologies beats Charles River Laboratories International on 11 of the 18 factors compared between the two stocks.

Get Charles River Laboratories International News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRL vs. The Competition

MetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE Exchange
Market Cap$11.06B$5.28B$5.24B$17.71B
Dividend YieldN/A1.24%2.74%3.55%
P/E Ratio25.2721.94139.7625.67
Price / Sales2.6974.952,404.8814.45
Price / Cash13.1925.8335.3920.21
Price / Book3.063.784.984.99
Net Income$474.62M$136.66M$110.61M$975.94M
7 Day Performance3.05%-4.96%-1.08%-1.87%
1 Month Performance-8.73%20.06%-0.68%-0.74%
1 Year Performance5.72%-11.07%2.90%8.66%

Charles River Laboratories International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
A
Agilent Technologies
4.6655 of 5 stars
$133.74
+0.1%
$136.50
+2.1%
+14.1%$39.02B$6.83B31.6218,100Insider Selling
MTD
Mettler-Toledo International
3.9681 of 5 stars
$1,450.94
-0.1%
$1,256.25
-13.4%
+8.2%$30.99B$3.79B40.6917,300
WAT
Waters
3.8771 of 5 stars
$301.87
-1.7%
$307.20
+1.8%
+17.5%$17.91B$2.96B29.627,900
ILMN
Illumina
4.7066 of 5 stars
$111.65
+4.6%
$162.29
+45.4%
-43.8%$17.79B$4.50B-13.709,300Analyst Forecast
News Coverage
TECH
Bio-Techne
3.9467 of 5 stars
$79.76
+0.6%
$81.00
+1.6%
-5.6%$12.57B$1.14B63.303,050Positive News
BRKR
Bruker
4.8814 of 5 stars
$64.82
+2.0%
$85.00
+31.1%
-14.4%$9.42B$2.96B23.579,707
BIO
Bio-Rad Laboratories
4.8207 of 5 stars
$291.86
+1.0%
$436.67
+49.6%
-23.0%$8.32B$2.67B-28.178,030
PACB
Pacific Biosciences of California
2.6044 of 5 stars
$2.02
-1.0%
$6.38
+215.7%
-85.6%$549.98M$200.52M-1.77796Gap Down
HBIO
Harvard Bioscience
1.8195 of 5 stars
$3.12
+1.6%
N/A-49.3%$135.50M$112.25M-15.60391Positive News
LIFE
aTyr Pharma
3.3919 of 5 stars
N/A$23.67
+∞
N/A$131.12M$350,000.000.0056Positive News

Related Companies and Tools

This page (NYSE:CRL) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners